Clarifying gastrointestinal toxicity attribution in WP-SBRT: Commentary on Dinesan et al. and proposal of a bladder-bowel displacement index.
作者信息
Altınışık İnan Gonca, Melis Basman Emine, Demir Serenay
机构信息
Department of Radiation Oncology, Ankara Yıldırım Beyazıt University, Faculty of Medicine, Ankara, Türkiye.
Department of Radiation Oncology, Ankara Bilkent City Hospital, Türkiye.
出版信息
Clin Transl Radiat Oncol. 2025 Jul 14;54:100995. doi: 10.1016/j.ctro.2025.100995. eCollection 2025 Sep.
Abstract
摘要
相似文献
1
Clarifying gastrointestinal toxicity attribution in WP-SBRT: Commentary on Dinesan et al. and proposal of a bladder-bowel displacement index.
Clin Transl Radiat Oncol. 2025 Jul 14;54:100995. doi: 10.1016/j.ctro.2025.100995. eCollection 2025 Sep.
2
Unmasking enteritis: reply to commentary titled "Clarifying Gastrointestinal toxicity attribution in WP-SBRT: A commentary on Dinesan et al. and proposal of a bladder-bowel displacement index".
Clin Transl Radiat Oncol. 2025 Jun 17;54:100996. doi: 10.1016/j.ctro.2025.100996. eCollection 2025 Sep.
3
Mitigation on bowel loops daily variations by 1.5-T MR-guided daily-adaptive SBRT for abdomino-pelvic lymph-nodal oligometastases.
J Cancer Res Clin Oncol. 2021 Nov;147(11):3269-3277. doi: 10.1007/s00432-021-03739-8. Epub 2021 Jul 15.
4
Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial.
Lancet Oncol. 2025 Jul;26(7):936-947. doi: 10.1016/S1470-2045(25)00205-0. Epub 2025 Jun 12.
5
Dosimetric Clues to Addressing Urinary Toxicity Following Stereotactic Prostate Radiation Therapy.
Adv Radiat Oncol. 2025 Jul 3;10(9):101850. doi: 10.1016/j.adro.2025.101850. eCollection 2025 Sep.
6
Lessons Learned About Acute and Late Toxicity After Two Decades of Experience With Pancreatic SBRT.
J Natl Compr Canc Netw. 2025 Jun 11;23(7):e257013. doi: 10.6004/jnccn.2025.7013.
7
Urethral and bladder dosimetry and urinary toxicity in prostate cancer patients undergoing SBRT with and without intra-prostatic boost.
Clin Transl Radiat Oncol. 2025 Jun 13;54:100993. doi: 10.1016/j.ctro.2025.100993. eCollection 2025 Sep.
8
Primary Analysis of (NCT03380806) a Phase II Randomized Trial of Stereotactic Body Radiotherapy Boost Versus Conventional Fractionation External Beam Radiotherapy Boost in Unfavorable-Intermediate and High-Risk Prostate Cancer.
Prostate. 2025 Jul;85(10):977-985. doi: 10.1002/pros.24905. Epub 2025 Apr 27.
9
CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer.
Clin Transl Radiat Oncol. 2023 Oct 24;44:100693. doi: 10.1016/j.ctro.2023.100693. eCollection 2024 Jan.
10
Oncological outcomes and safety after spinal reirradiation with stereotactic body radiotherapy.
J Neurosurg Spine. 2025 Sep 12:1-9. doi: 10.3171/2025.4.SPINE241281.
本文引用的文献
1
Acute enteritis with pelvic SBRT: Influence of bowel delineation methods.
Clin Transl Radiat Oncol. 2025 Feb 1;52:100926. doi: 10.1016/j.ctro.2025.100926. eCollection 2025 May.
2
Optimal image guided radiation therapy strategy for organs at risk sparing in radiotherapy of the prostate including pelvic lymph nodes.
Radiother Oncol. 2018 Apr;127(1):68-73. doi: 10.1016/j.radonc.2018.02.009. Epub 2018 Mar 2.
3
Radiation enteritis.
Curr Gastroenterol Rep. 2014;16(5):383. doi: 10.1007/s11894-014-0383-3.
4
Efficacy of glutamine in the prevention of acute radiation enteritis: a randomized controlled trial.
JPEN J Parenter Enteral Nutr. 2014 Feb;38(2):205-13. doi: 10.1177/0148607113478191. Epub 2013 Mar 7.
5
Acute radiation proctitis: a sequential clinicopathologic study during pelvic radiotherapy.
Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):1111-7. doi: 10.1016/s0360-3016(00)00744-6.
Zotero 插件